Summary not available.
AdTheorent (ADTH) reported a 6.5% revenue increase in Q2 2022, reaching $42.5 million, driven by strong performance in CTV and healthcare sectors. Despite a 39.2% decline in Adjusted EBITDA to $7.3 million, net income surged to $57.8 million, bolstered by mark to market gains. Active customers grew by 15% to 331. The company is expanding its predictive advertising capabilities and recently signed a data license with Peer 39. However, macroeconomic challenges may affect growth in the latter half of 2022.
AdTheorent (Nasdaq: ADTH), a top programmatic digital advertising company, announced its CEO, Jim Lawson, will present at the Canaccord Genuity 42nd Annual Growth Conference.
AdTheorent leverages advanced machine learning for advertising, consistently earning accolades in the industry.
AdTheorent Holding Company (Nasdaq: ADTH) announced it will report Q2 financial results on August 9, 2022, after market close. The company utilizes advanced machine learning technology to enhance programmatic digital advertising, focusing on privacy-forward solutions. Following the results, a conference call will occur at 4:30 p.m. ET to discuss the outcomes. This announcement highlights AdTheorent's commitment to delivering measurable value in advertising while maintaining a focus on non-sensitive data and predictive modeling.
AdTheorent (Nasdaq: ADTH) announced its inclusion in the Russell 3000® and Russell 2000® Indexes, effective June 27, 2022, following the annual reconstitution. This membership recognizes the company's market capitalization among the largest U.S. stocks and enhances visibility among investors, potentially driving increased interest in the company's services in programmatic digital advertising. Approximately $12 trillion in assets utilize Russell indexes as benchmarks, indicating significant market influence.
Summary not available.
AdTheorent has released its Advertising Trends Report, revealing that 82% of travelers use digital devices for trip research and 77% for booking. A notable 57% consider themselves 'revenge travelers,' eager to make up for lost time due to the pandemic, with 83% planning to splurge on travel expenses. The report emphasizes the effectiveness of tailored ads, showing that relevant ads boost brand perception and increase destination visits. Additionally, immersive ad formats, like 360-degree videos, significantly impact consumer actions, suggesting a pivotal shift in digital advertising for travel brands.
AdTheorent Holding Company (Nasdaq: ADTH) reported a 10.6% year-over-year increase in revenue for Q1 2022, reaching $34.2 million. Adjusted Gross Profit also rose by 10.5% to $23.0 million, although net income fell significantly to a loss of $42.3 million. The company experienced strong growth in CTV revenue, up 42% year-over-year. Key innovations, including new technology for campaign optimization, were highlighted. Looking ahead, AdTheorent forecasts Q2 2022 revenue between $45.2 million and $46.2 million. Overall, the results reflect commitment to profitable growth despite challenges.
AdTheorent (Nasdaq: ADTH) announced significant success in a digital advertising campaign for the Texas Renaissance Festival, achieving a 1729% lower cost-per-action (CPA) compared to social ads. The campaign, managed by StackRabbit, targeting adults aged 25-49, resulted in a 159% increase in e-commerce ticket sales revenue and 64.5K additional attendees compared to pre-COVID levels. AdTheorent's predictive targeting capabilities significantly outperformed traditional tactics, marking a successful application of advanced machine learning in advertising.
AdTheorent (Nasdaq: ADTH) released findings from its AdTheorentRx Healthcare Advertising Trends Report, revealing that 71% of consumers might consult their doctors after seeing mobile medication ads. The report, based on a Harris Poll survey of over 2,000 U.S. adults, highlights the importance of targeted digital ads, with 72% of consumers using digital devices during their patient journey. Notably, digital ad spending in healthcare is projected to rise 11.5% in 2022, reaching $13.63 billion. The insights indicate that relevant ads can significantly influence consumer behavior toward medications.